Clinical trial
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
NCT00474058 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00474058 |
|---|---|
| Title | Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine |
| Official title | Phase 3B, Multicenter, Multinational, Double-Blind, Placebo Controlled, 2-Arm Trial to Evaluate the Effect of the 24-Hour Transdermal Delivery of Rotigotine on the Control of Early Morning Motor Function, Sleep Quality, Nocturnal Symptoms, and Non-Motor Symptoms in Subjects With Idiopathic… |
| Acronym | RECOVER |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug, Other |
| Interventions | Rotigotine, Placebo |
| Enrollment | 287 |
| Start date | May 1, 2007 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | May 16, 2007 |
| Last update posted | Jun 22, 2015 |
| Countries | Australia, Austria, Finland, Germany, Hungary, Italy, New Zealand, Poland, South Africa, Spain, United Kingdom, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: